ATRC AtriCure, Inc.
AtriCure, Inc. (ATRC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 75% planned / 25% discretionary
Largest single sale: $407.6K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Privitera Salvatore | Chief Technical Officer | Sell 10b5-1 | 4,519 | $60.00 | $271.1K | 142,745 −3.1% of holding | |
| GROVES REGINA E | Director | Sell | 5,313 | $54.22 | $288.1K | 34,546 −13.3% of holding | |
| Privitera Salvatore | Chief Technical Officer | Sell 10b5-1 | 3,657 | $55.00 | $201.1K | 147,264 −2.4% of holding | |
| Privitera Salvatore | Chief Technical Officer | Sell 10b5-1 | 7,763 | $52.50 | $407.6K | 150,921 −4.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.